We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+0.26%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$30.7B
AUM Growth
+$988M
Cap. Flow
+$1.01B
Cap. Flow %
3.28%
Top 10 Hldgs %
54.65%
Holding
2,179
New
164
Increased
802
Reduced
752
Closed
188

Sector Composition

Rank Sector Weight
1 Financials 4.77%
2 Technology 4.11%
3 Healthcare 1.86%
4 Consumer Discretionary 1.76%
5 Industrials 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYGN icon
1501
Myriad Genetics
MYGN
$530M
$236K ﹤0.01%
+8,251
New +$240K
SAIL
1502
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$236K ﹤0.01%
12,636
+96
+0.8% +$2.04K
BYD icon
1503
Boyd Gaming
BYD
$6.47B
$235K ﹤0.01%
+9,828
New +$248K
PRLB icon
1504
Protolabs
PRLB
$1.86B
$235K ﹤0.01%
2,305
-151
-6% -$15.4K
FLS icon
1505
Flowserve
FLS
$9.25B
$233K ﹤0.01%
4,991
-262
-5% -$12.4K
GGT
1506
Gabelli Multimedia Trust
GGT
$170M
$233K ﹤0.01%
29,086
+257
+0.9% +$2.11K
JTA
1507
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
$233K ﹤0.01%
20,696
IRM icon
1508
Iron Mountain
IRM
$38.2B
$232K ﹤0.01%
+7,149
New +$225K
MRVL icon
1509
Marvell Technology
MRVL
$174B
$232K ﹤0.01%
+9,309
New +$234K
UHT
1510
Universal Health Realty Income Trust
UHT
$608M
$232K ﹤0.01%
2,256
-2,400
-52% -$226K
IHE icon
1511
iShares US Pharmaceuticals ETF
IHE
$1.47B
$231K ﹤0.01%
4,959
-285
-5% -$13.6K
NG icon
1512
NovaGold Resources
NG
$2.6B
$231K ﹤0.01%
37,975
+27,125
+250% +$178K
PRI icon
1513
Primerica
PRI
$9.81B
$231K ﹤0.01%
1,813
+33
+2% +$3.98K
QEP
1514
DELISTED
QEP RESOURCES, INC.
QEP
$231K ﹤0.01%
62,375
-56,455
-48% -$269K
DWM icon
1515
WisdomTree International Equity Fund
DWM
$666M
$230K ﹤0.01%
4,621
+122
+3% +$6.05K
FEZ icon
1516
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.28B
$230K ﹤0.01%
6,086
+59
+1% +$2.2K
NHI icon
1517
National Health Investors
NHI
$3.9B
$230K ﹤0.01%
2,793
+100
+4% +$8.14K
CFMS
1518
DELISTED
Conformis, Inc. Common Stock
CFMS
$230K ﹤0.01%
4,950
+2,393
+94% +$144K
AYR
1519
DELISTED
Aircastle Ltd
AYR
$230K ﹤0.01%
10,253
ALLY icon
1520
Ally Financial
ALLY
$13.1B
$229K ﹤0.01%
6,916
+35
+0.5% +$1.13K
AVP
1521
DELISTED
Avon Products, Inc.
AVP
$229K ﹤0.01%
52,034
OVV icon
1522
Ovintiv
OVV
$17.5B
$228K ﹤0.01%
9,930
+364
+4% +$8.34K
PSB
1523
DELISTED
PS Business Parks, Inc.
PSB
$228K ﹤0.01%
1,252
AEO icon
1524
American Eagle Outfitters
AEO
$2.85B
$227K ﹤0.01%
+13,980
New +$233K
ENPH icon
1525
Enphase Energy
ENPH
$4.84B
$226K ﹤0.01%
10,175
-34,418
-77% -$882K

Similar funds

Creative Planning's Q3 2019 Portfolio in Review

As of Q3 2019, Creative Planning held 2,179 positions worth $30.7B, up 3.3% from $29.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.01B of net new capital in Q3 2019, opening 164 new positions and adding to 802 existing holdings. Its largest new stake was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.

By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $92.7M trimmed.

  • Creative Planning's largest Q3 2019 buy was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $124M increase.
  • Creative Planning's biggest Q3 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $92.7M.
  • Creative Planning fully exited Total System Services, Inc. in Q3 2019, selling an estimated $49.4M.
  • Creative Planning's ten largest holdings make up 55% of its $30.7B portfolio in Q3 2019.
  • Creative Planning opened 164 new positions and closed 188 in Q3 2019.
  • Creative Planning's portfolio value rose 3.3% quarter-over-quarter to $30.7B.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.